![Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/attachment/5a3c1320-5d4d-42ba-bed6-e1060fa2102b/gr1.gif)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/asset/10e1989d-d781-4363-9ec6-0acbc75cf444/gr1.jpg)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![PDF) The Extent Application of Management Accounting Techniques, Case Study: Five Star Hotels in Jordan PDF) The Extent Application of Management Accounting Techniques, Case Study: Five Star Hotels in Jordan](https://i1.rgstatic.net/publication/318652719_The_Extent_Application_of_Management_Accounting_Techniques_Case_Study_Five_Star_Hotels_in_Jordan/links/5bb4759e45851574f7f7518f/largepreview.png)
PDF) The Extent Application of Management Accounting Techniques, Case Study: Five Star Hotels in Jordan
![Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/attachment/03197da1-e15f-4d52-bfd5-a54f3ccf9cec/gr1.gif)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
![Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/attachment/f15b7c82-70db-4f33-b149-37c261703c9a/gr1.gif)
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/attachment/6d0fb724-9766-4959-8a3d-180a77cde531/gr1.gif)